Chuansheng Zheng

Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitors

Bo Sun, Keke Si, Yiwan Guo, 2024, Frontiers in oncology.

Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response.

Yazhuo Zhao, Qing Li, Lijie Zhang, 2024, Cardiovascular and interventional radiology.

Inhibitory Effect of Extract of Fungi of Huaier on Hepatocellular Carcinoma Cells

Jian-lin Fang, X. Xia, Hui-min Liang, 2009 .

Prognosis of LSPD versus TIPS for the treatment of esophagogastric variceal bleeding in cirrhosis

P. Xu, Bingqing Ma, Chuansheng Zheng, 2024, Surgical endoscopy.

Drug-eluting beads transcatheter arterial chemoembolization combined with systemic therapy versus systemic therapy alone as first-line treatment for unresectable colorectal liver metastases

Yanyan Cao, Lei Chen, Jihua Wang, 2024, Frontiers in oncology.

Sorafenib plus transcatheter arterial chemoembolization with or without camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma

Lei Chen, Yiming Liu, Bo Sun, 2024, The British journal of radiology.

Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study

B. Liang, X. Xia, Haohao Lu, 2023, BMC Cancer.

Large-scale pretrained frame generative model enables real-time low-dose DSA imaging: An AI system development and multi-center validation study.

C. Majoie, A. van der Lugt, T. van Walsum, 2024, Med.

Efficacy and Safety of TACE Combined with Regorafenib versus TACE Combined with Camrelizumab in Hepatocellular Carcinoma With Untreatable Progression After TACE Combined with Sorafenib Therapy: A Case Control Study

Songlin Song, Yanqiao Ren, Yiming Liu, 2024, Cancer control : journal of the Moffitt Cancer Center.